RecruitingNCT06741553

Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Principal Investigator
Baorong Zhang, M.D.
Zhejiang University School of Medicine Second Affiliated Hospital
Intervention
Lecanemab 10 mg/kg(drug)
Enrollment
120 enrolled
Eligibility
85 years · All sexes
Timeline
2024 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06741553 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials